The pharma last month presented early-stage data for AZD6234 at the 2024 ObesityWeek of The Obesity Society, touting an encouraging safety profile and promising weight lossthough data around the candidate remain scant.
The dual incretin agonists segment held a 23% share of the market in 2025 and is expected to grow at a CAGR of 18.5% during the projection period
Despite extensive research, effective treatments for Alzheimers disease remain elusive
Ingredients: Water/Aqua/Eau, Propanediol, Pantethine, Glycerin, Tetrahexyldecyl Ascorbate, S-Palmitoylglutathione, Dimethyl MEA, Palmitoyl Tripeptide-38, Acetyl Tyrosine, Avena Sativa (Oat) Kernel Extract, Xanthan Gum, Macadamia Ternifolia Seed Oil, Linum Usitatissimum (Linseed) Seed Oil, Salvia Hispanica Seed Oil, Silica Cetyl Silylate, Ethylhexylglycerin, Sodium Hyaluronate, Helianthus Annuus (Sunflower) Seed Oil, Rosmarinus Officinalis (Rosemary) Leaf Extract, Tetrasodium Glutamate Diacetate, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Caprylyl Glycol, Hydroxypropyl Cyclodextrin, Phenoxyethanol, Silica, Titanium Dioxide (CI 77891), Iron Oxides (CI 77491) Gently pat onto eye area using your ring finger
